Skip to content
Screener

Veracyte VCYT Pre-Tax Income

Pre-Tax Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$34.1M-16.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.02M-90.7%
Guardant Health logo
Guardant HealthGH
-$111.7M-17.7%
Natera, Inc. logo
Natera, Inc.NTRA
-$67.23M+33.2%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$689.8M-927%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$81.2M+64.6%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.71B+97.6%
Enterprise value$3.48B+104%
P/E42.2×-29.1×
P/S6.9×+2.9×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Veracyte’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 8:07 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001384101-26-000031
Line itemThree Months Ended March 31, 20262025
Total operating expenses78,51376,604
Income from operations22,6462,904
Other income, net7,3284,524
Income before income taxes29,9747,428
Income tax provision1,267381
Net income$28,707$7,047
Earnings per share:
Basic$0.36$0.09

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Veracyte's pre-tax income?
Veracyte (VCYT) reported pre-tax income of $29.97M in Q1 2026.
How has Veracyte's pre-tax income changed year-over-year?
Veracyte's pre-tax income increased by 303.5% year-over-year, from $7.43M to $29.97M.
What is the long-term trend for Veracyte's pre-tax income?
Over 4 years (2021 to 2025), Veracyte's pre-tax income has grown at a -4.4% compound annual growth rate (CAGR), from -$81.65M to $68.2M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Veracyte's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude